Clients

Because of IDSC extensive drug discovery, drug development, and therapeutic area expertise, virtual, small, medium, and large biotech companies; large pharmaceutical companies, research foundations and academic institutions come to IDSC to help them get from early discovery through phase III clinical trials.  This is a partial list of IDSC's clients who have given permission to publish their names:

 

 

AOC

 

MIR

 

Affinium Pharmaceuticals

 

MaxThera

 

ApiGenisis

 

NAEJA Pharmaceuticals

 

Arsenal Capital Partners

 

Nektar Therapeutics

 

Biolytx Pharma

 

Novartis Venture Funds

 

Biota

 

Novel Chemical Solutions

 

BoroPharm     

 

Nymirum     

 

Cubist

 

Pfizer

 

Deciphera

 

Profectus Biosciences

 

Koo Foundation Sun Yat-Sen Cancer Center

 

 The University of Louisville

 

 

Print Print | Sitemap
© 2007-2014 IDSC, LLC.